Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
Completed
University of Glasgow
Phase 1
1995-10-01
RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping
blood flow to the tumor.
PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in
treating patients with solid tumors that have not responded to previous therapy.
National Center for Complementary and Integrative Health (NCCIH)
Phase 3
2003-09-01
The purpose of this study is to determine the safety and effectiveness of ethylene diamine
tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
The purpose of this study is to determine the safety and effectiveness of ethylene diamine
tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
The purpose of this study is to determine the safety and effectiveness of ethylene diamine
tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
Terminated
LEO Pharma
Phase 3
1999-11-01
To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended
curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol
injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation
therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
